Despite a small sample volume, a clear reduction in cell numbers could not be observed in the three follow-up patient samples with patient 1 showing a decline, patient 5 an increase and patient 9 a stable situation suggesting that a more complex situation influences response dynamics of CD44+ CRC across therapy and thereafter. Here, CD44 is linked to colorectal carcinoma.